MyFinsight
Home
Blog
About
agilon health, inc. (AGL)
agilon health, inc. (AGL)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$32,755K
Free Cash flow
-$60,744K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Proceeds from maturities of mark...
Stock-based compensation expense
Loss (income) from equity method...
Others
Negative Cash Flow Breakdown
Changes in operating assets and ...
Purchases of property, equipment...
Purchase of intangible assets
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
17,956
48,916
-188,882
-110,207
Depreciation and amortization
6,864
6,787
6,969
7,430
Stock-based compensation expense
23,832
6,255
9,520
7,498
Impairments
-
-
36,085
-
Loss (income) from equity method investments
-7,596
11,733
-33,052
13,133
Distributions of earnings from equity method investments
-
-
0
0
Adjustments on sale of assets, net
0
19,000
0
0
Other, net
-446
-931
-53
2,464
Receivables, net
-
-
-344,585
-
Prepaid expense and other current assets
-
-
65,439
-
Other assets
-
-
133
-
Medical claims and related payables
-
-
1,894
-
Accounts payable and accrued expenses
-
-
-85,585
-
Other liabilities
-
-
-2,065
-
Changes in operating assets and liabilities
113,991
115,231
-
-92,722
Net cash provided by (used in) operating activities
-57,297
23,728
-20,537
-18,154
Purchases of property, equipment, and capitalized software
3,447
3,101
2,968
3,175
Purchase of intangible assets
860
25
6,790
13,359
Investment in loans receivable and other
0
-
1,000
0
Investments in marketable securities
0
0
0
0
Proceeds from maturities of marketable securities and other
-
-
193,872
-
Net cash paid in business combination
-
-
0
-
Proceeds from sale of business and property, net of cash divested
-
-
0
-
Proceeds from maturities of marketable securities and other
24,218
-138,133
-
35,192
Net cash provided by (used in) investing activities
19,911
19,272
22,583
18,658
Proceeds from (payments for) equity issuances, net
4,631
-35
-17
-236
Common stock repurchase
-
-
0
-
Debt issuance costs
0
1,612
-
-
Repayments of long-term debt
0
3,500
0
0
Net cash provided by (used in) financing activities
4,631
-5,147
-17
-236
Net increase (decrease) in cash, cash equivalents and restricted cash and equivalents
-32,755
37,853
2,029
268
Cash, cash equivalents and restricted cash and equivalents, beginning of period
171,684
171,684
-
193,860
Cash, cash equivalents and restricted cash and equivalents, end of period
178,811
211,566
-
171,684
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Proceeds from maturities
of marketable...
$24,218K
(-80.68%↓ Y/Y)
Proceeds from (payments
for) equity...
$4,631K
(268.95%↑ Y/Y)
Net cash provided by
(used in) investing...
$19,911K
(-57.97%↓ Y/Y)
Net cash provided by
(used in) financing...
$4,631K
(268.95%↑ Y/Y)
Canceled cashflow
$4,307K
Net increase
(decrease) in cash, cash...
-$32,755K
(-45.94%↓ Y/Y)
Canceled cashflow
$24,542K
Stock-based compensation
expense
$23,832K
(-25.76%↓ Y/Y)
Net income (loss)
$17,956K
(119.46%↑ Y/Y)
Loss (income) from
equity method...
-$7,596K
(-142.00%↓ Y/Y)
Depreciation and
amortization
$6,864K
(-51.64%↓ Y/Y)
Other, net
-$446K
(-114.35%↓ Y/Y)
Purchases of property,
equipment, and capitalized...
$3,447K
(-51.44%↓ Y/Y)
Purchase of intangible
assets
$860K
(-91.15%↓ Y/Y)
Net cash provided by
(used in) operating...
-$57,297K
(14.57%↑ Y/Y)
Canceled cashflow
$56,694K
Changes in operating
assets and liabilities
$113,991K
(909.54%↑ Y/Y)
Buy us a coffee